Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
FOLD 11.01.2024
Date of Upcoming Event:2024-11-12
Name of Upcoming Event:Guggenheim Healthcare Innovation Conference
Date of Upcoming Event:2024-11-19
Name of Upcoming Event:Jefferies London Healthcare Conference
Date of Upcoming Event:2024-11-13
Name of Upcoming Event:J.P. Morgan Equity Opportunities Forum
About Gravity Analytica
PRINCETON, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November.
- Guggenheim Healthcare Innovation Conference in Boston, MA, on Tuesday, November 12, 2024, at 2:30 p.m. ET
- Jefferies London Healthcare Conference in London, U.K. on Tuesday, November 19, 2024, at 8:00 a.m. GMT
A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website athttps://ir.amicusrx.com/events-and-presentations.
Additionally, management will attend the J.P. Morgan Equity Opportunities Forum on Wednesday, November 13, 2024.
About Amicus TherapeuticsAmicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website atwww.amicusrx.com, and follow onXandLinkedIn.
CONTACT:
Investors:Amicus TherapeuticsAndrew FaughnanVice President, Investor Relationsafaughnan@amicusrx.com(609) 662-3809
Media:Amicus TherapeuticsDiana MooreHead of Global Corporate Affairs and Communicationsdmoore@amicusrx.com(609) 662-5079
FOLD–G
